The CrystecPharma team had an exceptional few days at CPHI Frankfurt 2025, connecting with industry leaders, partners, and innovators from across the global pharmaceutical sector.
The event provided a valuable opportunity for insightful discussions, knowledge sharing, and collaboration, as the team engaged with both long-standing partners and new connections.
Throughout the conference, CrystecPharma highlighted its expertise in particle engineering, demonstrating how its advanced technologies help pharmaceutical companies optimise solubility, stability, and bioavailability for both small and large molecules.
CPHI continues to be a key platform for fostering innovation and partnership across the pharmaceutical industry, and CrystecPharma was proud to contribute to the conversation on advancing drug development and delivery.
If you did not have a chance to meet with the CrystecPharma team, please send us a message here.